BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34423490)

  • 1. Inhibition of spindle and kinetochore associated complex subunit 3 suppresses the proliferation and invasion and induced the apoptosis of cutaneous melanoma by affecting the PI3K/Akt pathway.
    Liang Y; Zheng Y; Mou K; Han D; Wang L; Ge R; Meng A
    J Biochem Mol Toxicol; 2021 Nov; 35(11):e22895. PubMed ID: 34423490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling.
    Zhang J; Liu Y; Pu S; He J; Zhou C
    Breast Cancer Res Treat; 2021 Feb; 186(1):247-258. PubMed ID: 33423159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
    Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
    Li C; Yang J; Lei S; Wang W
    Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway.
    Niu Z; Li Y; Xu Y; Jiang W; Tao R; Chen Y; Han Y
    Bioengineered; 2021 Dec; 12(2):12193-12205. PubMed ID: 34783295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKA3 promotes lung adenocarcinoma metastasis through the EGFR-PI3K-Akt axis.
    Hu DD; Chen HL; Lou LM; Zhang H; Yang GL
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis.
    Gao W; Zhang Y; Luo H; Niu M; Zheng X; Hu W; Cui J; Xue X; Bo Y; Dai F; Lu Y; Yang D; Guo Y; Guo H; Li H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Ma T; Jin L; Xu W; Wu Y
    Cell Death Dis; 2020 Oct; 11(10):919. PubMed ID: 33106477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway.
    Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG
    J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spindle and kinetochore-related complex subunit 3 has a protumour function in osteosarcoma by activating the Notch pathway.
    Liang G; Duan C; He J; Shi L
    Toxicol Appl Pharmacol; 2024 Feb; 483():116826. PubMed ID: 38228236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.
    Hou Y; Wang Z; Huang S; Sun C; Zhao J; Shi J; Li Z; Wang Z; He X; Tam NL; Wu L
    Cell Death Dis; 2019 Dec; 10(12):929. PubMed ID: 31804459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of SKA3 enhances cell proliferation and correlates with poor prognosis in hepatocellular carcinoma.
    Tang J; Liu J; Li J; Liang Z; Zeng K; Li H; Zhao Z; Zhou L; Jiang N
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ska3 is required for spindle checkpoint silencing and the maintenance of chromosome cohesion in mitosis.
    Daum JR; Wren JD; Daniel JJ; Sivakumar S; McAvoy JN; Potapova TA; Gorbsky GJ
    Curr Biol; 2009 Sep; 19(17):1467-72. PubMed ID: 19646878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ-SKA3 upregulates ID3 expression by decoying miR-326 to accelerate the development of medulloblastoma.
    Zhao X; Guan J; Luo M
    J Clin Neurosci; 2021 Apr; 86():87-96. PubMed ID: 33775353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways.
    Tang R; Xu X; Yang W; Yu W; Hou S; Xuan Y; Tang Z; Zhao S; Chen Y; Xiao X; Huang W; Guo W; Li M; Deng W
    Cancer Lett; 2016 Apr; 373(1):77-87. PubMed ID: 26797421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway.
    Long J; Pi X
    Biomed Res Int; 2020; 2020():5149417. PubMed ID: 32733943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway.
    Hu R; Wang MQ; Niu WB; Wang YJ; Liu YY; Liu LY; Wang M; Zhong J; You HY; Wu XH; Deng N; Lu L; Wei LB
    Cancer Cell Int; 2018; 18():183. PubMed ID: 30459531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.
    Silva JM; Bulman C; McMahon M
    Mol Cancer Res; 2014 Mar; 12(3):447-63. PubMed ID: 24425783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition.
    Chen WY; Xu YY; Zhang XY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.